A61K 31/065
Diphenyl-substituted acyclic alcohols
A61K31/065 (Diphenyl-substituted acyclic alcohols) appears on 57 US grants and 100 published applications in this corpus.
Search patents in A61K- Granted patents
- 57
- Published applications
- 100
- Assignees
- 63
- Inventors
- 185
- Latest grant
- 27 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 2 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 3 |
| 2007 | 1 | 1 |
| 2008 | 0 | 2 |
| 2009 | 0 | 2 |
| 2010 | 3 | 2 |
| 2011 | 0 | 3 |
| 2012 | 0 | 1 |
| 2013 | 1 | 1 |
| 2014 | 2 | 5 |
| 2015 | 3 | 5 |
| 2016 | 3 | 4 |
| 2017 | 2 | 7 |
| 2018 | 2 | 10 |
| 2019 | 3 | 16 |
| 2020 | 9 | 10 |
| 2021 | 8 | 12 |
| 2022 | 4 | 4 |
| 2023 | 5 | 6 |
| 2024 | 3 | 3 |
| 2025 | 4 | 1 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods of potentiating antimicrobials27 Jan 2026US 12,533,370 B2Neurothera Labs Inc.
- Water soluble compositions comprising purified cannabinoids2 Dec 2025US 12,485,129 B2Canopy Growth Corporation
- Eye health supplement with curcumin18 Nov 2025US 12,472,153 B2Qh Holdings (Oregon), Inc.
- Water soluble compositions comprising purified cannabinoids10 Jun 2025US 12,324,801 B2Canopy Growth Corporation
- Water soluble compositions comprising purified cannabinoids29 Apr 2025US 12,285,405 B2Canopy Growth Corporation
- Use of cannabinoids in the treatment of epilepsy5 Jun 2025US 2025/0177321 A1GW Research Limited
- Emulsion composition26 Dec 2024US 2024/0423911 A1AstaReal Co., Ltd.
- Bacteriophage preparations and methods of use12 Dec 2024US 2024/0408156 A1The Regents of the University of California
- Eye health supplement with curcumin24 Oct 2024US 2024/0350429 A1Qh Holdings (Oregon), Inc.
- Intraocular delivery of bioactive molecules using iontophoresis19 Oct 2023US 2023/0329906 A1Kemin Industries, Inc.
Most cited
By later US patents
- Methods and products for treating diarrhea and scours: use of clotrimazole and related aromatic compounds20US 5,889,038 AChildren's Hospital, Inc. · 1999
- Triaryl methane compounds and their use in the treatment of diarrhea and scours18US 6,495,567 B1Beth Israel Deaconess Medical Center, Inc. · 2002
- Pharmaceutical compositions comprising cannabidiol derivatives15US 7,759,526 B2Yissum Research Development Company · 2010
- Compositions for potentiating glutathione9US 7,740,831 B2Fancl Corporation · 2010
- Water soluble compositions comprising purified cannabinoids8US 10,568,865 B2Canopy Growth Corporation · 2020